These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Genetic polymorphisms potentially associated with response to metformin in postmenopausal diabetics suffering and not suffering with cancer. Berstein LM; Iyevleva AG; Vasilyev D; Poroshina TE; Imyanitov EN Cell Cycle; 2013 Dec; 12(23):3681-8. PubMed ID: 24145224 [TBL] [Abstract][Full Text] [Related]
45. Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy. Vona-Davis L; Rose DP Curr Diabetes Rev; 2012 Mar; 8(2):116-30. PubMed ID: 22268396 [TBL] [Abstract][Full Text] [Related]
46. Summaries for patients. Metformin for patients with type 2 diabetes mellitus. Ann Intern Med; 2002 Jul; 137(1):I50. PubMed ID: 12093266 [No Abstract] [Full Text] [Related]
47. Role of metformin in type II diabetes. Epstein S Cleve Clin J Med; 1995; 62(5):278-9. PubMed ID: 7586481 [No Abstract] [Full Text] [Related]
56. The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes. Walford GA; Colomo N; Todd JN; Billings LK; Fernandez M; Chamarthi B; Warner AS; Davis J; Littleton KR; Hernandez AM; Fanelli RR; Lanier A; Barbato C; Ackerman RJ; Khan SQ; Bui R; Garber L; Stolerman ES; Moore AF; Huang C; Kaur V; Harden M; Taylor A; Chen L; Manning AK; Huang P; Wexler D; McCarthy RM; Lo J; Thomas MK; Grant RW; Goldfine A; Hudson MS; Florez JC PLoS One; 2015; 10(3):e0121553. PubMed ID: 25812009 [TBL] [Abstract][Full Text] [Related]
58. The Effect of Metformin on Survival Outcomes of Non-Metastatic Breast Cancer Patients with Type 2 Diabetes. Behrouzi B; Zokaasadi M; Mohagheghi MA; Emami AH; Sadighi S Asian Pac J Cancer Prev; 2021 Feb; 22(2):611-616. PubMed ID: 33639681 [TBL] [Abstract][Full Text] [Related]
59. A proof of concept, preliminary study to determine the effect of Yogasnas in controlling type 2 diabetes mellitus in newly detected subjects (when compared to metformin monotherapy). Viswanathan V; Chacko PT; Lavanya M; Tilak P J Assoc Physicians India; 2006 Dec; 54():965-6. PubMed ID: 17334022 [No Abstract] [Full Text] [Related]
60. Metformin and ovarian cancer survival: is there a rational warrant for belief? Mormile R Arch Gynecol Obstet; 2019 Oct; 300(4):797-798. PubMed ID: 31346700 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]